Skip to content

Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus

Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus: a Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01748305
Enrollment
14
Registered
2012-12-12
Start date
2012-12-31
Completion date
2013-12-31
Last updated
2015-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Gestational Diabetes Mellitus

Keywords

GDM, A1GDM, A2GDM

Brief summary

Patients with newly diagnosed gestational diabetes will be recruited. The control group with get routine diet and exercise counseling. The intervention group will be instructed to get moderate-to-vigorous intensity exercise; they will walk on a treadmill one time with supervision in order to be instructed how hard to work. All participants will keep an exercise log for 3 weeks and will wear an accelerometer for 1 week. The primary outcome is glucose control, specifically the need for medication in treatment of their diabetes. The hypothesis is that moderate or greater intensity exercise will better control glucose and lead to less need for medication management.

Interventions

BEHAVIORALModerate-to-vigorous intensity exercise

Moderate-to-vigorous intensity exercise three times per day for three weeks

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* gestational diabetes mellitus * singelton pregnancy * 18 years old or older * no medical contraindications to exercise

Exclusion criteria

* multiple gestation * non-English speaking * unable to exercise * preexisting diabetes

Design outcomes

Primary

MeasureTime frame
Need for medication for diabetes3 weeks

Secondary

MeasureTime frame
Birth weightdelivery
A1cdelivery
Mode of deliverydelivery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026